For example, a recent study by Zhao et al. of seven patients with LMD secondary to EGFR-positive TKI-resistent NSCLC patients found that a majority of patients were EGFR sensitive in CSF but not in plasma, possibly indicating poor TKI CSF penetration [146]. Here, EGFR is linked to non-small cell lung carcinoma.